LCC-12 formate
Based on 1 Customer Validation
LCC-12 formate is a mitochondria-targeted Copper2+ -selective binder and metabolic/epigenetic reprogramming agent. LCC-12 formate inhibits NAD (H) redox cycling and reduces the NAD (H) pool. LCC-12 formate downregulates the expression of inflammatory genes and improves outcomes in mouse models of bacterial sepsis, endotoxemia, and SARS-CoV-2 infection. LCC-12 formate can be used in research related to acute inflammation, endotoxemia, sepsis, and SARS-CoV-2 infection.
For research use only. We do not sell to patients.
- Purity : 99.90%
- Formula: C17H38N10O2
- Molecular Weight:414.55
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
In Vitro
LCC-12 formate inhibits copper (II)-catalyzed redox cycling of NADH to NAD+ in a dose-dependent manner in a cell-free system mimicking the mitochondrial matrix[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Molecular Weight 414.55
-
Formula C17H38N10O2
-
Color White to off-white
-
SMILES
NC(NC(NCCCCCCCCCCCCNC(NC(N)=N)=N)=N)=N.O=CO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (267 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Solier S, et al. A druggable copper-signalling pathway that drives inflammation. Nature. 2023 May;617(7960):386-394. [Content Brief]
[3]. Weiskirchen R. Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy. Signal Transduct Target Ther. 2023 Sep 11;8(1):339. [Content Brief]
[4]. Flemming A, et al. Copper boosts pro-inflammatory state of macrophages. Nature reviews. Immunology. 2023 Jun;23(6):344. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)